1. Natural History of NAFLD/NASH;Ekstedt;Curr. Hepatol. Rep.,2017
2. The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis;Riazi;Lancet Gastroenterol. Hepatol.,2022
3. Risk of Hepatocellular Cancer in Patients with Non-Alcoholic Fatty Liver Disease;Kanwal;Gastroenterology,2018
4. GBD 2017 Cirrhosis Collaborators (2020). The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol., 5, 245–266.
5. Global Burden of Disease Cancer Collaboration, Fitzmaurice, C., Abate, D., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdel-Rahman, O., Abdelalim, A., Abdoli, A., and Abdollahpour, I. (2019). Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol., 5, 1749–1768.